GSK-692342
N/A
Report date: 2025/08/01 20:01:42
Base Information
Drug NameGSK-692342
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[7]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A
Develop Information
Active CompaniesGates Medical Research Institute
Inactive CompaniesGlaxosmithkline PlcCorixa Corp
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A